DRUG: AVM0703
DRUG: Fludarabine
RADIATION: Total-Body Irradiation
PROCEDURE: Donor Lymphocyte Infusion
DRUG: Cyclophosphamide
DRUG: Tacrolimus
DRUG: Mycophenolate Mofetil
PROCEDURE: Hematopoietic Cell Transplantation
DRUG: Melphalan
PROCEDURE: Bone Marrow Aspiration and Biopsy
PROCEDURE: Diagnostic Imaging
PROCEDURE: Biospecimen Collection
PROCEDURE: Biospecimen Collection
BIOLOGICAL: Chimeric Antigen Receptor T-Cell Therapy
PROCEDURE: Computed Tomography
RADIATION: External Beam Radiation Therapy
PROCEDURE: Leukapheresis
PROCEDURE: Magnetic Resonance Imaging
PROCEDURE: Positron Emission Tomography
DRUG: rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone
DRUG: rituximab and lenalidomide
DRUG: rituximab and bendamustine
DRUG: rituximab, cytarabine, dexamethasone, and oxaliplatin/carboplatin
DRUG: gemcitabine and oxaliplatin
BIOLOGICAL: Epcoritamab
DRUG: rituximab, cyclophosphamide, reduced dose of doxorubicin, vincristine, and prednisone
DRUG: Lenalidomide
DRUG: rituximab, ifosfamide, carboplatin, and etoposide phosphate
BIOLOGICAL: Epcoritamab
BIOLOGICAL: Epcoritamab
BIOLOGICAL: Epcoritamab
BIOLOGICAL: Epcoritamab
BIOLOGICAL: Epcoritamab
BIOLOGICAL: Epcoritamab
BIOLOGICAL: Epcoritamab
DRUG: Pembrolizumab
DRUG: Doxorubicin
DRUG: Vinblastine
DRUG: Dacarbazine
DRUG: Brentuximab vedotin
DRUG: Polatuzumab Vedotin
BIOLOGICAL: Rituximab
DRUG: Prednisone
DRUG: Etoposide
DRUG: Doxorubicin
DRUG: Cyclophosphamide
BIOLOGICAL: Glofitamab
PROCEDURE: Multigated Acquisition Scan
PROCEDURE: Echocardiography
PROCEDURE: FDG-Positron Emission Tomography
PROCEDURE: Computed Tomography
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspiration
DIAGNOSTIC_TEST: NGS-MRD
DRUG: Myeloablative allogeneic HCT with a non-TBI conditioning regimen
DRUG: Ruxolitinib
DRUG: Nivolumab
BIOLOGICAL: Chimeric Antigen Receptor T-Cell Therapy
DRUG: Cyclophosphamide
DRUG: Fludarabine Phosphate
BIOLOGICAL: Rituximab
BIOLOGICAL: 19-28z/IL-18 CAR T cells
DRUG: Glofitamab
DRUG: Obinutuzumab
DRUG: Axi-cel
DRUG: Alectinib
DRUG: Crizotinib
OTHER: Clinical Observation
DRUG: Crizotinib
OTHER: Laboratory Biomarker Analysis
BIOLOGICAL: CD19x22 CAR T
BIOLOGICAL: EBV-specific T cells: A
BIOLOGICAL: EBV-specific T cells: B
BIOLOGICAL: zamtocabtagene autoleucel (MB-CART2019.1)
DRUG: Cyclophosphamide
DRUG: Fludarabine
DRUG: Bendamustine
DRUG: VIP943
DRUG: Venetoclax monotherapy
DRUG: Venetoclax with anti CD20 monoclonal antibody
DRUG: CD47 Antagonist ALX148
DRUG: Lenalidomide
BIOLOGICAL: Rituximab
DRUG: Mogamulizumab
DRUG: Brentuximab vedotin
BIOLOGICAL: Obinutuzumab
BIOLOGICAL: Glofitamab
DRUG: Pirtobrutinib
PROCEDURE: Tumor Imaging
PROCEDURE: Biospecimen Collection
DEVICE: ClonoSeq Assay
PROCEDURE: Bone Marrow Biopsy
DRUG: Venetoclax
DRUG: Lenalidomide
DRUG: Rituximab
PROCEDURE: Biospecimen Collection
PROCEDURE: Dual X-ray Absorptiometry
DRUG: Tegavivint
PROCEDURE: X-Ray Imaging
DEVICE: Alpha/Beta T-cell and B-cell depleted HCT
DRUG: Blinatumomab
PROCEDURE: Computed Tomography
PROCEDURE: Endoscopic Procedure
RADIATION: Involved-site Radiation Therapy (3 Fractions)
RADIATION: Involved-site Radiation Therapy (12 Fractions)
PROCEDURE: Positron Emission Tomography
OTHER: Questionnaire Administration
DRUG: SC Mosunetuzumab
DRUG: IV Glofitamab
DRUG: CC-220
DRUG: CC-99282
DRUG: Obinutuzumab
DRUG: Tocilizumab
RADIATION: Radiation Therapy
DRUG: Dexamethasone
DRUG: Etoposide phosphate
DRUG: Ifosfamide
DRUG: Mesna
DRUG: Carboplatin
BIOLOGICAL: Basiliximab
DRUG: Carmustine
DRUG: Cytarabine
DRUG: Etoposide
BIOLOGICAL: Genetically Engineered Hematopoietic Stem Progenitor Cells
BIOLOGICAL: Recombinant Granulocyte Colony-Stimulating Factor
BIOLOGICAL: Yttrium Y 90 Basiliximab
DRUG: SG2501
DRUG: Oral repotrectinib (TPX-0005)
DRUG: cemsidomide
DRUG: Dexamethasone Oral
DRUG: ONO-4685
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspiration
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Dual-Energy Computed Tomography
PROCEDURE: Echocardiography
DRUG: Fludarabine
PROCEDURE: Magnetic Resonance Imaging
DRUG: Melphalan
PROCEDURE: Multigated Acquisition Scan
BIOLOGICAL: Partially Engineered T-regulatory Cell Donor Graft TRGFT-201
DRUG: Tacrolimus
DRUG: Thiotepa
RADIATION: Total Marrow and Lymphoid Irradiation
DRUG: Rituximab
DRUG: Pirtobrutinib
DRUG: Fenretinide
DRUG: Epcoritamab
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspiration
DRUG: Calaspargase Pegol
DRUG: Cytarabine
PROCEDURE: Echocardiography
DRUG: Fludarabine Phosphate
DRUG: Hydrocortisone Sodium Succinate
PROCEDURE: Lumbar Puncture
DRUG: Methotrexate
PROCEDURE: Multigated Acquisition Scan
DRUG: Prednisolone
DRUG: Prednisone
DRUG: Revumenib
DRUG: Vincristine Sulfate
DRUG: LP-168
DRUG: LP-168
DRUG: CTO1681 10 μg
DRUG: CTO1681 20 μg
DRUG: CTO1681 30 μg
DRUG: MT-601
GENETIC: CAR T Cells
BIOLOGICAL: Blinatumomab
OTHER: Laboratory Biomarker Analysis
BIOLOGICAL: Pembrolizumab
DRUG: Methotrexate
DRUG: pralatraxate,
DRUG: Ifosfamide
DRUG: Dexamethasone
DRUG: Etoposide
DRUG: calaspargase pegol
DRUG: cyclophosphamide
DRUG: Doxorubicin
DRUG: Prednisone
DRUG: Brentuximab Vedotin
BIOLOGICAL: Peripheral Blood Stem Cell Transplant
DRUG: Allopurinol 300 MG
DRUG: Fludarabine
DRUG: Cyclophosphamide
BIOLOGICAL: Bone Marrow Cell Transplant
RADIATION: Total Body Irradiation
DRUG: Sirolimus Pill
DRUG: Mycophenolate Mofetil
BIOLOGICAL: ATLCAR.CD30 cells
BIOLOGICAL: JCAR017 (lisocabtagene maraleucel)
BIOLOGICAL: JCAR017 (lisocabtagene maraleucel) + ibrutinib
BIOLOGICAL: JCAR017 (lisocabtagene maraleucel) + venetoclax
DRUG: Belinostat
PROCEDURE: Biopsy
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
OTHER: Pharmacokinetic Study
PROCEDURE: Positron Emission Tomography and Computed Tomography Scan
DRUG: Tazemetostat
DRUG: APG-5918
DRUG: WTX-330
DRUG: Polatuzumab vedotin
DRUG: Rituximab
DRUG: Cyclophosphamide
DRUG: Doxorubicin
DRUG: Prednisone
DRUG: Odronextamab
DRUG: Conditioning Chemotherapy
BIOLOGICAL: Cord blood graft
PROCEDURE: Extracorporeal Photopheresis
BIOLOGICAL: Mogamulizumab
OTHER: Quality-of-Life Assessment
OTHER: Questionnaire Administration
DRUG: E7777
DRUG: Daratumumab / Hyaluronidase Injection
DRUG: Daratumumab / Hyaluronidase Injection
DRUG: Daratumumab / Hyaluronidase Injection
DRUG: Daratumumab / Hyaluronidase Injection
DRUG: Mervometostat (PF-06821497)
DRUG: Enzalutamide
BIOLOGICAL: Autologous Anti-CD19 CAR-expressing T-lymphocytes IC19/1563
DRUG: Bendamustine
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspiration
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Computed Tomography
DRUG: Cyclophosphamide
DRUG: Fludarabine
PROCEDURE: Magnetic Resonance Imaging
PROCEDURE: Positron Emission Tomography
DRUG: Prednisone
DRUG: Rituximab
DRUG: Cyclophosphamide
DRUG: Vincristine
DRUG: Epcoritamab
PROCEDURE: Bone Marrow Biopsy
DRUG: Cyclophosphamide
DRUG: Doxorubicin
DRUG: Prednisone
BIOLOGICAL: Retifanlimab
BIOLOGICAL: Rituximab and Hyaluronidase Human
BIOLOGICAL: Tafasitamab
DRUG: Vincristine
PROCEDURE: Bone Marrow Aspiration
PROCEDURE: Multigated Acquisition Scan
OTHER: Fludeoxyglucose F-18
PROCEDURE: Positron Emission Tomography
PROCEDURE: Computed Tomography
PROCEDURE: Biospecimen Collection
DRUG: Polatuzumab Vedotin
BIOLOGICAL: Fully human anti CD19 CAR-T Cell Dose
DRUG: Fludarabine
DRUG: Cyclophosphamide
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Computed Tomography
OTHER: Electronic Health Record Review
BIOLOGICAL: Epcoritamab
DRUG: Lenalidomide
PROCEDURE: Magnetic Resonance Imaging
PROCEDURE: Positron Emission Tomography
DRUG: Ruxolitinib
DRUG: Venetoclax
DRUG: Dexamethasone
DRUG: Inotuzumab Ozogamicin
DRUG: CM4620
DRUG: DA-EPOCH
BIOLOGICAL: Rituximab
DRUG: CHOP
DRUG: Acalabrutinib
DRUG: ABBV-525
DRUG: Pembrolizumab
DRUG: Pralatrexate
DRUG: Decitabine
DRUG: BET Bromodomain Inhibitor ZEN-3694
PROCEDURE: Core Biopsy
DRUG: Entinostat
DIETARY_SUPPLEMENT: Nicotinamide Riboside
DIETARY_SUPPLEMENT: Placebo
OTHER: Exercise Intervention
BIOLOGICAL: UCART22
BIOLOGICAL: CLLS52
DRUG: Durvalumab
DRUG: Acalabrutinib
DRUG: Mosunetuzumab
DRUG: Lenalidomide
DRUG: Rituximab
DRUG: Tociluzumab
DRUG: Pembrolizumab
DRUG: Flt3L
RADIATION: Radiation
DRUG: Poly ICLC
BIOLOGICAL: Zilovertamab vedotin
DRUG: Nemtabrutinib
BIOLOGICAL: CAR-20/19-T cells (5 x 10^5 CAR-20/19-T cells/kg)
BIOLOGICAL: CAR-20/19-T cells (1 x10^6 CAR-20/19-T cells/kg)
BIOLOGICAL: CAR-20/19-T cells (2.5 x10^6 CAR-20/19-T cells/kg)
BIOLOGICAL: CAR-20/19-T cells
DRUG: VMD-928 300 mg Tablet (ongoing); 100 mg Capsule (complete)
BIOLOGICAL: Inotuzumab Ozogamicin
DRUG: Zanubrutinib
DRUG: Obinutuzumab
DRUG: Venetoclax
DRUG: Calaspargase pegol (S95015)
OTHER: Quality-of-Life Assessment
OTHER: Questionnaire Administration
RADIATION: Radiation Therapy
BIOLOGICAL: Blinatumomab
DRUG: Ibrutinib
OTHER: Clinical Observation
RADIATION: Radiation Therapy
BIOLOGICAL: Rituximab
BIOLOGICAL: MABEL CTLs
DRUG: Cyclophosphamide
DRUG: Fludarabine
DRUG: Isatuximab
OTHER: Standard Procedures
BIOLOGICAL: EO2463
DRUG: lenalidomide
BIOLOGICAL: rituximab
DRUG: Tazemetostat
DRUG: Tazemetostat
DRUG: Placebo oral tablet
COMBINATION_PRODUCT: Lenalidomide
COMBINATION_PRODUCT: Rituximab
BIOLOGICAL: CD19/CD22 CAR T-Cells
DRUG: Fludarabine
DRUG: Cyclophosphamide
DRUG: Pirtobrutinib
DRUG: Venetoclax
DRUG: Rituximab
BIOLOGICAL: EB103
DRUG: Nemtabrutinib
DRUG: Itacitinib
DRUG: Cyclophosphamide
DRUG: Cytarabine
DRUG: Daunorubicin Hydrochloride
DRUG: Mercaptopurine
DRUG: Methotrexate
DRUG: Pegaspargase
DRUG: Prednisone
DRUG: Venetoclax
DRUG: Vincristine Sulfate
DRUG: Cyclophosphamide
DRUG: Fludarabine
BIOLOGICAL: Lisocabtagene Maraleucel
DRUG: Polymer-conjugated IL-15 Receptor Agonist NKTR-255
PROCEDURE: X-Ray Imaging
PROCEDURE: Echocardiography
PROCEDURE: Multigated Acquisition Scan
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Bone Marrow Aspiration
PROCEDURE: Lumbar Puncture
PROCEDURE: Computed Tomography
PROCEDURE: Positron Emission Tomography
PROCEDURE: Biospecimen Collection
PROCEDURE: Biopsy
DRUG: Mosunetuzumab
DRUG: Zanubrutinib
DRUG: Tafasitamab
DRUG: Lenalidomide
GENETIC: CD7.CAR/28zeta CAR T cells
BIOLOGICAL: Axicabtagene Ciloleucel
DRUG: Cyclophosphamide
DRUG: Fludarabine
DRUG: Lenalidomide
DRUG: Rituximab
DRUG: Doxorubicin
DRUG: Vincristine
DRUG: Prednisone
DRUG: Bendamustine
DRUG: Rituximab
DRUG: Lenalidomide
DRUG: Valemetostat
DRUG: Cyclophosphamide
DRUG: Fludarabine
DRUG: ACE1831
DRUG: Obinutuzumab
DRUG: Chimeric Antigen Receptor (CAR) T-Cell Product (Autologous)
DRUG: Ruxolitinib
DRUG: Asparaginase Erwinia chrysanthemi
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspiration and Biopsy
DRUG: Calaspargase Pegol
DRUG: Cyclophosphamide
DRUG: Cytarabine
PROCEDURE: Diagnostic Imaging
BIOLOGICAL: Inotuzumab Ozogamicin
DRUG: Leucovorin Calcium
PROCEDURE: Lumbar Puncture
DRUG: Methotrexate
DRUG: Pegaspargase
DRUG: Vincristine
DRUG: Bendamustine Hydrochloride
DRUG: Brentuximab Vedotin
DRUG: Xembify
DRUG: Placebo
DRUG: Blinatumomab
DRUG: Asciminib
DRUG: Acalabrutinib
BIOLOGICAL: Axicabtagene Ciloleucel
DRUG: Busulfan
DRUG: Busulfan
DRUG: Fludarabine
RADIATION: Total-body irradiation
DRUG: Cyclophosphamide
DRUG: Melphalan
PROCEDURE: PBSC Hematopoietic Stem Cell Transplantation (HSCT)
PROCEDURE: Bone Marrow Hematopoietic Stem Cell Transplantation
DRUG: Post-transplant Cyclophosphamide
DRUG: Mesna
DRUG: Tacrolimus
DRUG: Mycophenolate Mofetil
OTHER: Patient-Reported Outcomes
BIOLOGICAL: Anti-CD19/CD20/CD22 CAR T-Cells
DRUG: Cyclophosphamide
DRUG: Fludarabine Phosphate
DRUG: Emavusertib
DRUG: ibrutinib
PROCEDURE: Biopsy
PROCEDURE: Biospecimen Collection
DRUG: Carboplatin
PROCEDURE: Computed Tomography
DRUG: Etoposide
DRUG: Ifosfamide
DRUG: Lenalidomide
PROCEDURE: Positron Emission Tomography
BIOLOGICAL: Tafasitamab
BIOLOGICAL: Sacituzumab tirumotecan
DRUG: Docetaxel
DRUG: Pemetrexed
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspiration
DRUG: Busulfan
DRUG: Cyclophosphamide
PROCEDURE: Echocardiography
DRUG: Fludarabine
PROCEDURE: Haploidentical Hematopoietic Cell Transplantation
BIOLOGICAL: Lapine T-Lymphocyte Immune Globulin
PROCEDURE: Lumbar Puncture
PROCEDURE: Matched Unrelated Donor Hematopoietic Cell Transplantation
DRUG: Melphalan
DRUG: Methotrexate
PROCEDURE: Multigated Acquisition Scan
DRUG: Mycophenolate Mofetil
PROCEDURE: Myeloablative Conditioning
OTHER: Quality-of-Life Assessment
OTHER: Questionnaire Administration
BIOLOGICAL: Rituximab
PROCEDURE: T-Cell Depletion Therapy
DRUG: Tacrolimus
DRUG: Thiotepa
RADIATION: Total-Body Irradiation
DRUG: Glofitamab
DRUG: Obinutuzumab
DRUG: Lenalidomide
BIOLOGICAL: NKX019
DRUG: MRX-2843
DRUG: Busulfan
DRUG: Fludarabine
PROCEDURE: PBSC Hematopoietic Stem Cell Transplantation (HSCT)
DRUG: Post-Transplant Cyclophosphamide
DRUG: Mesna
DRUG: Tacrolimus
DRUG: Mycophenolate Mofetil
OTHER: Patient Reported Outcomes
DRUG: Melphalan
RADIATION: Total-body irradiation
DRUG: Cyclophosphamide
BIOLOGICAL: Axicabtagene Ciloleucel
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
DRUG: Cyclophosphamide
DRUG: Fludarabine
BIOLOGICAL: Lisocabtagene Maraleucel
BIOLOGICAL: Mosunetuzumab
OTHER: Patient Observation
DRUG: Polatuzumab Vedotin
PROCEDURE: Positron Emission Tomography
BIOLOGICAL: Tisagenlecleucel
DRUG: voruciclib monotherapy
DRUG: voruciclib and venetoclax
DRUG: SAR443579
DRUG: Acalabrutinib
BIOLOGICAL: Obinutuzumab
DRUG: Venetoclax
DRUG: Acalabrutinib
BIOLOGICAL: Obinutuzumab
OTHER: Quality-of-Life Assessment
OTHER: Questionnaire Administration
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspiration
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Bone Scan
DRUG: Calaspargase Pegol
PROCEDURE: Computed Tomography
DRUG: Cyclophosphamide
DRUG: Cytarabine
DRUG: Daunorubicin Hydrochloride
DRUG: Dexamethasone
DRUG: Doxorubicin Hydrochloride
BIOLOGICAL: Inotuzumab Ozogamicin
DRUG: Leucovorin Calcium
PROCEDURE: Magnetic Resonance Imaging
DRUG: Mercaptopurine
DRUG: Methotrexate
DRUG: Pegaspargase
PROCEDURE: Positron Emission Tomography
DRUG: Prednisolone
OTHER: Questionnaire Administration
RADIATION: Radiation Therapy
RADIATION: Radiation Therapy
DRUG: Thioguanine
DRUG: Vincristine Sulfate
DRUG: IDP-023
DRUG: Rituximab
DRUG: Daratumumab
DRUG: Interleukin-2
DRUG: Cyclophosphamide
DRUG: Fludarabine
DRUG: Mesna
DRUG: Selinexor
DRUG: Epcoritamab
DRUG: Rituximab
DIETARY_SUPPLEMENT: Cholecalciferol
OTHER: Laboratory Biomarker Analysis
BIOLOGICAL: CNTY-101
BIOLOGICAL: IL-2
DRUG: Lymphodepleting Chemotherapy
DRUG: Zanubrutinib
DRUG: Tafasitamab
DRUG: APG2575
BIOLOGICAL: Autologous BAFFR-targeting CAR T Cells
DRUG: Bendamustine
PROCEDURE: Biopsy
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspiration and Biopsy
PROCEDURE: Computed Tomography
DRUG: Cyclophosphamide
PROCEDURE: Echocardiography
DRUG: Fludarabine
PROCEDURE: Leukapheresis
PROCEDURE: Magnetic Resonance Imaging
PROCEDURE: Positron Emission Tomography
DRUG: Dexamethasone
DRUG: Mitoxantrone
DRUG: PEG asparaginase
DRUG: Bortezomib
DRUG: Vorinostat
DRUG: Mercaptopurine
DRUG: Methotrexate
DRUG: Blinatumomab
DRUG: Ziftomenib
DRUG: Acalabrutinib
BIOLOGICAL: Obinutuzumab
DRUG: Nemtabrutinib
DRUG: Fludarabine
DRUG: Cyclophosphamide
DRUG: Bendamustine
BIOLOGICAL: Rituximab
BIOLOGICAL: Truxima
BIOLOGICAL: Ruxience
BIOLOGICAL: Riabni
DRUG: Cyclophosphamide
DRUG: CAR.70/IL15-transduced CB-NK cells
DRUG: Fludarabine phosphate
DRUG: Cyclophosphamide injection
DRUG: Fludarabine Injection
BIOLOGICAL: CD19-CD34t metabolically programmed CAR transduced T-cells
DRUG: Hypericin
OTHER: Visible Light
PROCEDURE: Biopsy
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
BIOLOGICAL: Loncastuximab Tesirine
BIOLOGICAL: Mosunetuzumab
PROCEDURE: Positron Emission Tomography
DRUG: Odronextamab
DRUG: Rituximab
DRUG: Cyclophosphamide
DRUG: Doxorubicin
DRUG: Vincristine
DRUG: Prednisone/prednisolone
DRUG: Bendamustine
BIOLOGICAL: Pneumococcal 20-valent Conjugate Vaccine
BIOLOGICAL: Pneumococcal Polyvalent Vaccine
OTHER: Questionnaire Administration
DRUG: ABBV-291
DRUG: Decitabine
DRUG: Dexamethasone
DRUG: Palbociclib
DRUG: Sorafenib
DRUG: IPH6501
RADIATION: Total-Body Irradiation
DRUG: Thiotepa
DRUG: Fludarabine
DRUG: Cyclophosphamide
DRUG: Busulfan
PROCEDURE: Allogeneic Bone Marrow Transplantation
DRUG: Tacrolimus
DRUG: Methotrexate
PROCEDURE: Naive T Cell-Depleted Hematopoietic Stem Cell Transplantation
PROCEDURE: Echocardiography
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspiration
PROCEDURE: Bone Marrow Biopsy
DEVICE: Vysis LSI MYC Break Apart Rearrangement Probe Kit
DRUG: venetoclax
DRUG: VIP152
DRUG: prednisone
GENETIC: KUR-502
DRUG: Azacytidine
DRUG: Pembrolizumab
DRUG: Nemtabrutinib
DRUG: Venetoclax
BIOLOGICAL: Rituximab
BIOLOGICAL: iC9-CAR19 cells
DRUG: Rimiducid
DRUG: Cyclophosphamide
DRUG: Fludarabine
DRUG: CC-99282
DRUG: Rituximab
DRUG: Obinutuzumab
DRUG: Tafasitamab
DRUG: Valemetostat
GENETIC: CD19.CAR-aNKT cells
BIOLOGICAL: Anti-Thymocyte Globulin
DRUG: Cyclophosphamide
BIOLOGICAL: Cytokine-treated Veto Cells
DRUG: Fludarabine
PROCEDURE: Peripheral Blood Stem Cell Transplantation
RADIATION: Total-Body Irradiation
DRUG: Obinutuzumab
DRUG: CC-99282
DRUG: Loncastuximab tesirine 150 µg/Kg
DRUG: Loncastuximab tesirine 75µg/Kg
BIOLOGICAL: Autologous, humanized anti-CD22 CAR T cell therapy (CART22-65s)
BIOLOGICAL: Autologous, humanized anti-CD19 CAR T cell therapy (huCART19)
DRUG: KB-0742
DRUG: CD22CART Infusion
DRUG: Zanubrutinib
BIOLOGICAL: CD19/CD22-CAR-transduced T cells
DRUG: cyclophosphamide
DRUG: fludarabine
DRUG: NX-2127
DRUG: BGB-11417
DRUG: Zanubrutinib
DRUG: Imiquimod
RADIATION: Radiation Therapy
DRUG: Cyclophosphamide
DRUG: Doxorubicin
DRUG: Etoposide
DRUG: Prednisone
BIOLOGICAL: Rituximab
BIOLOGICAL: Tafasitamab
DRUG: Vincristine
PROCEDURE: Bone Marrow Aspiration
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Computed Tomography
PROCEDURE: Lumbar Puncture
PROCEDURE: Biospecimen Collection
BIOLOGICAL: Azer-cel
DRUG: Fludarabine
DRUG: Cyclophosphamide
DRUG: IL-2
DRUG: Bendamustine
PROCEDURE: Biopsy
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
DRUG: Dacarbazine
DRUG: Doxorubicin
PROCEDURE: Echocardiography
PROCEDURE: Multigated Acquisition Scan
BIOLOGICAL: Pembrolizumab
PROCEDURE: Positron Emission Tomography
DRUG: Vinblastine
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
PROCEDURE: Positron Emission Tomography
DRUG: Tegavivint
PROCEDURE: Allogeneic Hematopoietic Stem Cell Transplantation
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspiration
PROCEDURE: Bone Marrow Biopsy
BIOLOGICAL: CD19CAR-CD28-CD3zeta-EGFRt-expressing Tn/mem-enriched T-lymphocytes
BIOLOGICAL: Cetuximab
PROCEDURE: Computed Tomography
DRUG: Cyclophosphamide
PROCEDURE: Echocardiography
DRUG: Fludarabine
PROCEDURE: Leukapheresis
PROCEDURE: Magnetic Resonance Imaging
PROCEDURE: Multigated Acquisition Scan
PROCEDURE: Positron Emission Tomography
BIOLOGICAL: Tisagenlecleucel
PROCEDURE: Allogeneic Hematopoietic Stem Cell Transplantation
DRUG: Cyclophosphamide
DRUG: Cyclosporine
BIOLOGICAL: Filgrastim
DRUG: Fludarabine
DRUG: Mycophenolate Mofetil
DRUG: Mycophenolate Sodium
RADIATION: Total-Body Irradiation
DRUG: Treosulfan
PROCEDURE: Bone Marrow Aspiration
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Echocardiography
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
PROCEDURE: Positron Emission Tomography
DRUG: Loncastuximab Tesirine
DRUG: Rituximab
DRUG: Gemcitabine
DRUG: Oxaliplatin
BIOLOGICAL: Dose Level 1A: 2 x 10^7 cells/m2
BIOLOGICAL: Dose Level 2A: 6 x 10^7 cells/m2
BIOLOGICAL: Dose Level 2B: 6 x 10^7 cells/m2
BIOLOGICAL: Dose Level 3B: 2 x 10^8 cells/m2
BIOLOGICAL: Dose Level 3A: 2 x 10^8 cells/m2
DRUG: N-Acetylcysteine
DRUG: Pomalidomide
DRUG: Nivolumab
DRUG: Cyclophosphamide
DRUG: Fludarabine
DRUG: Fludarabine Phosphate
BIOLOGICAL: Granulocyte Colony-Stimulating Factor
PROCEDURE: Hematopoietic Cell Transplantation
PROCEDURE: Intensity-Modulated Radiation Therapy
DRUG: Mycophenolate Mofetil
DRUG: Tacrolimus
DRUG: Brentuximab vedotin
DRUG: Pembrolizumab
DIETARY_SUPPLEMENT: Ascorbic Acid
DRUG: Carboplatin
DRUG: Cisplatin
DRUG: Cytarabine
DRUG: Dexamethasone
DRUG: Etoposide
DRUG: Gemcitabine Hydrochloride
DRUG: Ifosfamide
OTHER: Laboratory Biomarker Analysis
DRUG: Oxaliplatin
OTHER: Placebo Administration
OTHER: Questionnaire Administration
BIOLOGICAL: Rituximab
DRUG: Decitabine
PROCEDURE: Biospecimen Collection
PROCEDURE: Core Biopsy
PROCEDURE: Bone Marrow Aspiration
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Echocardiography
PROCEDURE: Positron Emission Tomography
PROCEDURE: Magnetic Resonance Imaging
PROCEDURE: Central Venous Cannula Insertion
PROCEDURE: Portacath Placement
PROCEDURE: Computed Tomography
GENETIC: Dose Level 1, VNX-101
GENETIC: Dose Level 2, VNX-101
GENETIC: Dose Level 3, VNX-101
GENETIC: Dose Level 4, VNX-101
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
DRUG: Decitabine and Cedazuridine
BIOLOGICAL: Nivolumab
PROCEDURE: Positron Emission Tomography
DRUG: Choline Salicylate
DRUG: Selinexor
DRUG: ATA3219
BIOLOGICAL: iC9-CAR19 T cells
DRUG: Bendamustine
DRUG: Fludarabine
DRUG: AP1903
DRUG: Cyclophosphamide
DRUG: Cyclophosphamide
DRUG: Fludarabine
BIOLOGICAL: KITE-363
BIOLOGICAL: KITE-753
BIOLOGICAL: Zilovertamab vedotin
DRUG: LP-284
BEHAVIORAL: CHAMPS-II adapted to adults 60+ years in HCT setting
DRUG: Efineptakin alfa
DRUG: Tisagenlecleucel
DRUG: Axicabtagene ciloleucel
DRUG: Lisocabtagene Maraleucel
BIOLOGICAL: Allogeneic Natural Killer Cell Line NK-92
BIOLOGICAL: Anti-Thymocyte Globulin
DRUG: Busulfan
DRUG: Clofarabine
DRUG: Cyclophosphamide
DRUG: Fludarabine Phosphate
OTHER: Laboratory Biomarker Analysis
DRUG: Melphalan
BIOLOGICAL: Rituximab
RADIATION: Total-Body Irradiation
PROCEDURE: Umbilical Cord Blood Transplantation
DRUG: Acalabrutinib
DRUG: Rituximab
OTHER: Brexucabtagene Autoleucel
DRUG: Cyclophosphamide
DRUG: Fludarabine Phosphate
DRUG: Dasatinib
DRUG: Methotrexate
DRUG: Prednisone
BIOLOGICAL: Rituximab
DRUG: Venetoclax
BIOLOGICAL: Blinatumomab
PROCEDURE: Bone Marrow Aspiration and Biopsy
PROCEDURE: Lumbar Puncture
PROCEDURE: Biospecimen Collection
DRUG: Venetoclax
DRUG: Azacitidine
DRUG: Cytarabine
DRUG: Methotrexate
DRUG: Hydrocortisone
DRUG: Leucovorin
DRUG: Dexamethasone
DRUG: Vincristine
DRUG: Doxorubicin
DRUG: Dexrazoxane
DRUG: Calaspargase Pegol
DRUG: Erwinia asparaginase
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspiration
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Computed Tomography
DRUG: Ibrutinib
PROCEDURE: Positron Emission Tomography
BIOLOGICAL: Rituximab
DRUG: Venetoclax
RADIATION: Viewray MRIdian® Linac
DRUG: Chemotherapy
BIOLOGICAL: Cell infusion
DRUG: Hyperbaric oxygen
DRUG: Mosunetuzumab
DRUG: Lenalidomide
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspiration
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Computed Tomography
BIOLOGICAL: Obinutuzumab
OTHER: Quality-of-Life Assessment
OTHER: Questionnaire Administration
DRUG: Venetoclax
GENETIC: ALLO-501A
BIOLOGICAL: ALLO-647
DRUG: Fludarabine
DRUG: Cyclophosphamide
DRUG: AN4005-dose level 0
DRUG: AN4005-dose level 1
DRUG: AN4005-dose level 2
DRUG: AN4005-dose level 3
DRUG: AN4005-dose level 4
DRUG: AN4005-food effect
BIOLOGICAL: SCRI-CAR22v2
BIOLOGICAL: Blinatumomab
DRUG: Cyclophosphamide
DRUG: Cytarabine
DRUG: Dexamethasone
DRUG: Doxorubicin Hydrochloride
BIOLOGICAL: Inotuzumab Ozogamicin
OTHER: Laboratory Biomarker Analysis
DRUG: Mercaptopurine
DRUG: Methotrexate
BIOLOGICAL: Ofatumumab
DRUG: Prednisone
BIOLOGICAL: Rituximab
DRUG: Vincristine Sulfate
DEVICE: CliniMACS
DRUG: KITE-197
DRUG: Cyclophosphamide
DRUG: Fludarabine
DRUG: CTX-8371
DRUG: Cyclophosphamide
DRUG: Fludarabine
BIOLOGICAL: Mogamulizumab
BIOLOGICAL: Natural Killer Cell Therapy
OTHER: Quality-of-Life Assessment
OTHER: Questionnaire Administration
DRUG: Ruxolitinib
DRUG: Cyclophosphamide
DRUG: Cytarabine
DRUG: Mercaptopurine
DRUG: Vincristine
DRUG: Pegaspargase
DRUG: Rituximab
DRUG: Methotrexate (Intrathecal Administration)
DRUG: Methotrexate (Intravenous Administration)
DRUG: Dexamethasone
DRUG: Doxorubicin
DRUG: Thioguanine
DRUG: Methotrexate Oral Product
DRUG: Golcadomide
DRUG: Rituximab
DRUG: Cyclophosphamide
DRUG: Doxorubicin
DRUG: Vincristine
DRUG: Prednisone
DRUG: Bendamustine
DRUG: SC291
DRUG: Fecal Microbiota Transplantation
PROCEDURE: Chemotherapy
PROCEDURE: CAR-T Therapy
DRUG: Acalabrutinib
DRUG: Nemtabrutinib
DRUG: Ibrutinib
DRUG: Acalabrutinib
BIOLOGICAL: Pneumococcal conjugate vaccine (PCV13)
BIOLOGICAL: CD19 targeted CAR T Cell Therapy
DRUG: Daratumumab SC
DRUG: Inotuzumab ozogamicin
DRUG: Methotrexate
DRUG: Hydrocortisone
DRUG: Cytarabine
DRUG: Diphenhydramine
DRUG: Acetaminophen
DRUG: Methylprednisolone
PROCEDURE: Biospecimen Collection
DRUG: Cyclophosphamide
DRUG: Doxorubicin Hydrochloride
DRUG: Oral Azacitidine
DRUG: Prednisone
OTHER: Questionnaire Administration
BIOLOGICAL: Rituximab
DRUG: Vincristine Sulfate
DRUG: Obinutuzumab
DRUG: Glofitamab
DRUG: Rituximab
DRUG: Ifosfamide
DRUG: Carboplatin
DRUG: Etoposide
DRUG: Tocilizumab
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
PROCEDURE: Magnetic Resonance Imaging
BIOLOGICAL: Mosunetuzumab
PROCEDURE: Positron Emission Tomography
OTHER: Questionnaire Administration
DRUG: IKS03
DRUG: Etoposide
DRUG: BCNU
DRUG: AraC
DRUG: Melphalan
PROCEDURE: Peripheral blood stem cell transplantation
BIOLOGICAL: G-CSF
DRUG: Cyclophosphamide
RADIATION: Total Body Irradiation
DRUG: Tagraxofusp
DRUG: Fludarabine
DRUG: Cytarabine
DRUG: Dexamethasone
DRUG: Vincristine
DRUG: Azacitidine
DRUG: Methotrexate
DRUG: Cytarabine IT
DRUG: Hydrocortisone
BIOLOGICAL: CTX112
BIOLOGICAL: Murine CART19
BIOLOGICAL: 19(T2)28z1xx TRAC T cell
DRUG: TURALIO(R)
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
DRUG: Lenalidomide
PROCEDURE: Magnetic Resonance Imaging
PROCEDURE: Positron Emission Tomography
OTHER: Quality-of-Life Assessment
OTHER: Questionnaire Administration
BIOLOGICAL: Tafasitamab
DRUG: Tazemetostat
DRUG: Zanubrutinib
BIOLOGICAL: ADCT-602
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspiration and Biopsy
PROCEDURE: Bone Scan
PROCEDURE: Computed Tomography
DRUG: Ensartinib
OTHER: Laboratory Biomarker Analysis
PROCEDURE: Magnetic Resonance Imaging
OTHER: Pharmacological Study
PROCEDURE: Positron Emission Tomography
PROCEDURE: Radionuclide Imaging
PROCEDURE: X-Ray Imaging
DRUG: RNK05047
DRUG: Polatuzumab vedotin
DRUG: AZD0486 IV
DRUG: Daratumumab
DRUG: revumenib
DRUG: cobicistat
PROCEDURE: Haploidentical Bone Marrow/Kidney
PROCEDURE: Biopsy
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
PROCEDURE: Echocardiography
PROCEDURE: Magnetic Resonance Imaging
DRUG: UAE Inhibitor TAK-243
DRUG: TAB004
DRUG: Toripalimab
DRUG: CS5001
PROCEDURE: Cognitive Assessment
BIOLOGICAL: Obinutuzumab
OTHER: Quality of Life Assessment
DRUG: Loncastuximab tesirine
DRUG: Venetoclax
DRUG: Brentuximab Vedotin
DRUG: Cyclophosphamide
DRUG: Doxorubicin
BIOLOGICAL: Nivolumab
DRUG: Prednisone
OTHER: Quality-of-Life Assessment
BIOLOGICAL: Rituximab
DRUG: AFM13
DRUG: AB-101
DRUG: Cyclophosphamide
DRUG: Fludarabine
DRUG: Interleukin-2
DRUG: ACALABRUTINIB
DRUG: LISOCABTAGENE MARALEUCEL
DRUG: Lymphodepleting chemotherapy
RADIATION: Total Body Irradiation 1200 cGy
RADIATION: Total Body Irradiation 200 cGy
DRUG: Cyclophosphamide
DRUG: Mesna
PROCEDURE: Cord Blood Infusion
DRUG: Busulfan
DRUG: Fludarabine
DRUG: Melphalan
DRUG: ONO-7018
DRUG: ONO-7018
DRUG: Acalabrutinib
BIOLOGICAL: Durvalumab
DRUG: Venetoclax
DRUG: Dasatinib
DRUG: Brentuximab Vedotin
OTHER: Laboratory Biomarker Analysis
BIOLOGICAL: Nivolumab
DRUG: Mosunetuzumab
DRUG: Polatuzumab vedotin
DRUG: Tafasitamab
DRUG: Lenalidomide
BIOLOGICAL: Autologous Humanized CD19-Directed Chimeric Antigen Receptor T-Cells (huCART19)
DRUG: Duvelisib
BIOLOGICAL: Tisagenlecleucel
BIOLOGICAL: Axicabtagene Ciloleucel
DRUG: Cyclophosphamide
DRUG: Fludarabine
DRUG: Etoposide
DRUG: Rituximab
DRUG: Doxorubicin
DRUG: Vincristine
DRUG: Prednisone
DRUG: Fludarabine
DRUG: Cyclophosphamide
RADIATION: Total Body Irradiation
DRUG: Cyclosporine A
DRUG: Mycophenylate mofetil
BIOLOGICAL: Umbilical cord blood
DRUG: APG-115
DRUG: APG-2575
DRUG: Brentuximab Vedotin
BIOLOGICAL: Nivolumab
DRUG: Tecartus
DRUG: Obinutuzumab
DRUG: Glofitamab
DRUG: Rituximab
DRUG: Bendamustine
DRUG: Lenalidomide
DRUG: Tocilizumab
DRUG: Acalabrutinib
OTHER: Laboratory Biomarker Analysis
BIOLOGICAL: Obinutuzumab
OTHER: Patient Observation
OTHER: Quality-of-Life Assessment
DRUG: Ketorolac
DRUG: Normal saline
DRUG: Acetaminophen
DRUG: Oxycodone Acetaminophen
DRUG: Morphine
DRUG: Hydrocodone/Acetaminophen
DRUG: Oxycodone
DRUG: Pembrolizumab
RADIATION: Involved Site Radiation Therapy
DRUG: NKTR-255 at 1.5 µg/kg
DRUG: NKTR-255 at 3.0 μg/kg
DRUG: NKTR-255 at 3.0/6.0 μg/kg
OTHER: Placebo Comparator
DRUG: Pembrolizumab
DRUG: Mogamulizumab
DRUG: Blinatumomab
DRUG: Low-intensity chemotherapy regimen
DRUG: SOC chemotherapy regimen
DRUG: FT522
DRUG: Rituximab
DRUG: Cyclophosphamide
DRUG: Fludarabine
DRUG: Bendamustine
BIOLOGICAL: COVID-19 Vaccine
OTHER: Diagnostic Laboratory Biomarker Analysis
BIOLOGICAL: Synthetic MVA-based SARS-CoV-2 Vaccine GEO-CM04S1
RADIATION: Involved site radiotherapy
DRUG: Doxorubicin
DRUG: Bleomycin
DRUG: Brentuximab vedotin
DRUG: Vinblastine
DRUG: Dacarbazine
DRUG: Haematopoietic growth factor
DEVICE: CliniMACS Cell Processing System for TCRαβ + T Cell and CD45RA Depleted Peripheral Stem Cell Addback
BIOLOGICAL: SIRPant-M
RADIATION: External-beam radiotherapy (XRT)
DRUG: AC676
DRUG: Acalabrutinib
DRUG: Venetoclax
DRUG: Siltuximab
DRUG: Pembrolizumab
DRUG: Methotrexate
DRUG: Temozolomide
DRUG: Rituximab
BIOLOGICAL: Zilovertamab vedotin
BIOLOGICAL: Rituximab
DRUG: Gemcitabine
DRUG: Oxaliplatin
DRUG: Bendamustine
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
PROCEDURE: Echocardiography
BIOLOGICAL: Pembrolizumab
PROCEDURE: Positron Emission Tomography
DRUG: Tazemetostat
DRUG: AB-101
DRUG: Rituximab
DRUG: Interleukin-2
DRUG: Cyclophosphamide
DRUG: Fludarabine
DRUG: Bendamustine
DRUG: Fludarabine
DRUG: Busulfan
DRUG: Melphalan
DRUG: Rituximab
DRUG: Levetiracetam
DRUG: JNJ-90009530
DRUG: LP-118
DRUG: Ponatinib
DRUG: Vincristine
DRUG: Dexamethasone
DRUG: Methotrexate
DRUG: DSP-5336
DRUG: Bortezomib plus Clofarabine
DRUG: pembrolizumab
DRUG: gemcitabine
DRUG: vinorelbine
DRUG: liposomal doxorubicin
PROCEDURE: Stem cell mobilization and collection
DRUG: Fludarabine
DRUG: Cyclophosphamide
BIOLOGICAL: PRGN-3007
DRUG: ARV-393
DRUG: Axicabtagene Ciloleucel
DRUG: Cyclophosphamide
DRUG: Fludarabine phosphate
DRUG: Prednisone
DRUG: Diphenhydramine
DRUG: Acetaminophen
DRUG: Tazemetostat Pill
DRUG: Atezolizumab
OTHER: Laboratory Biomarker Analysis
BIOLOGICAL: Obinutuzumab
DRUG: Venetoclax
DRUG: Englumafusp alfa
DRUG: Obinutuzumab
DRUG: Glofitamab
DRUG: Tocilizumab
DRUG: Zanubrutinib Pill
DRUG: Venetoclax Pill
DRUG: Obinutuzumab Injection
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspirate
DRUG: Cyclophosphamide
DRUG: Cyclosporine
PROCEDURE: Diagnostic Imaging
PROCEDURE: Echocardiography
DRUG: Fludarabine Phosphate
PROCEDURE: Multigated Acquisition Scan
DRUG: Mycophenolate Mofetil
OTHER: Survey Administration
DRUG: Thiotepa
RADIATION: Total-Body Irradiation
PROCEDURE: Umbilical Cord Blood Transplantation
DRUG: Eflapegrastim
DRUG: Chemotherapy
PROCEDURE: Biopsy
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Computed Tomography
BIOLOGICAL: Glofitamab
DRUG: Lenalidomide
BIOLOGICAL: Obinutuzumab
PROCEDURE: Positron Emission Tomography
DRUG: Venetoclax
BIOLOGICAL: pembrolizumab
BIOLOGICAL: Favezelimab
DRUG: Venetoclax Oral Tablet [Venclexta]
BIOLOGICAL: Cohort 1
BIOLOGICAL: Cohorts 2
BIOLOGICAL: Cohort 3
RADIATION: Bridging radiotherapy (BRT)
DRUG: Conditioning chemotherapy
BIOLOGICAL: CAR T-cell product
DRUG: ABBV-319
DRUG: Mosunetuzumab
DRUG: Ibrutinib
DRUG: Pembrolizumab
DRUG: Acalabrutinib
DRUG: Cyclophosphamide
DRUG: Doxorubicin Hydrochloride
DRUG: Lenalidomide
DRUG: Prednisone
BIOLOGICAL: Rituximab
BIOLOGICAL: Tafasitamab
DRUG: Vincristine
DRUG: CYC140
DRUG: Blinatumomab
DRUG: Odronextamab
DRUG: Rituximab
DRUG: Cyclophosphamide
DRUG: Doxorubicin
DRUG: Vincristine
DRUG: Prednisone/Prenisolone
BIOLOGICAL: BEAM-201
DRUG: CD79b-19 CAR T cells
DRUG: Cyclophosphamide
DRUG: Fludarabine
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspiration
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Computed Tomography
PROCEDURE: Magnetic Resonance Imaging
DRUG: Pirtobrutinib
PROCEDURE: Positron Emission Tomography
DRUG: Venetoclax
PROCEDURE: Echocardiography
PROCEDURE: Multigated Acquisition Scan
PROCEDURE: Biopsy
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Computed Tomography
OTHER: Fludeoxyglucose F-18
BIOLOGICAL: Mosunetuzumab
PROCEDURE: Positron Emission Tomography
BIOLOGICAL: Rituximab
BIOLOGICAL: Rituximab and Hyaluronidase Human
DRUG: Bendamustine
DRUG: Rituximab
DRUG: Tazemetostat
DRUG: CD19x22 CAR T Cells
PROCEDURE: Biopsy
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
DRUG: Golcadomide
PROCEDURE: Positron Emission Tomography
BIOLOGICAL: Rituximab
DRUG: SGR-1505
DRUG: Gemcitabine
DRUG: Pembrolizumab
DRUG: Mosunetuzumab
DRUG: Polatuzumab vedotin
DRUG: Tirabrutinib
DRUG: Tirabrutinib
DRUG: Tirabrutinib
BIOLOGICAL: Epcoritamab
BIOLOGICAL: Epcoritamab
DRUG: rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone
DRUG: Venetoclax
BIOLOGICAL: Epcoritamab
DRUG: Lenalidomide
DRUG: Acalabrutinib
DRUG: AZD0486
DRUG: Itacitinib
BIOLOGICAL: Chimeric antigen receptor (CAR) T-cell therapy
DRUG: Azacytidine
DRUG: Romidepsin
DRUG: Belinostat
DRUG: Pralatrexate
DRUG: Gemcitabine
BIOLOGICAL: obinutuzumab
DRUG: prednisone
DRUG: Revlimid
BIOLOGICAL: Polatuzumab
DRUG: ibrutinib
DRUG: venetoclax
DRUG: Cyclophosphamide
DRUG: Vincristine
DRUG: Blinatumomab
DRUG: Methotrexate
DRUG: Cytarabine
DRUG: Mercaptopurine
DRUG: Prednisone
DRUG: Pegfilgrastim
DRUG: Inotuzumab ozogamicin
DRUG: Rituximab
DRUG: Dexamethasone
BIOLOGICAL: AUTO1
BIOLOGICAL: Anti-CD19-CAR CMV-specific T-lymphocytes
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Computed Tomography
PROCEDURE: Leukapheresis
PROCEDURE: Lymphodepletion Therapy
PROCEDURE: Magnetic Resonance Imaging
BIOLOGICAL: Multi-peptide CMV-Modified Vaccinia Ankara Vaccine
PROCEDURE: Positron Emission Tomography
PROCEDURE: X-Ray Imaging
DRUG: Loncastuximab Tesirine
DRUG: HCB101
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
DRUG: Ontorpacept
BIOLOGICAL: Pembrolizumab
PROCEDURE: Positron Emission Tomography
DRUG: Maplirpacept
PROCEDURE: Biopsy
DRUG: Zanubrutinib
DRUG: Rituximab
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
BIOLOGICAL: Mosunetuzumab
PROCEDURE: Positron Emission Tomography
BIOLOGICAL: Rituximab
BIOLOGICAL: Rituximab and Hyaluronidase Human
DRUG: Mogamulizumab
RADIATION: LD TSEBT
DRUG: Fludarabine
OTHER: Laboratory Biomarker Analysis
DRUG: Melphalan
RADIATION: Total Marrow Irradiation
DRUG: Loncastuximab tesirine
DRUG: Rituximab
DRUG: Alintegimod
DRUG: Ipilimumab
DRUG: Nivolumab
BIOLOGICAL: Orca-Q
BIOLOGICAL: Autologous HuCD19 ( Anti-CD19)CAR T cells
DRUG: Cyclophosphamide
DRUG: Fludarabine
DRUG: Rituximab
DRUG: Inotuzumab ozogamicin
DRUG: Dasatinib
DRUG: Dexamethasone
DRUG: Methotrexate
DRUG: Vincristine
DRUG: Ponatinib
DRUG: Methotrexate for Injection
PROCEDURE: Allogenic Stem Cell Transplantation
DRUG: Fadraciclib
GENETIC: Autologous CD5.CAR/28zeta CAR T cells
GENETIC: Allogeneic CD5.CAR/28zeta CAR T cells
DRUG: Venetoclax
DRUG: Ibrutinib
DRUG: Prednisone
BIOLOGICAL: Obinutuzumab
DRUG: Revlimid (lenalidomide)
DRUG: Oral MRT-2359
DRUG: Oral MRT-2359
DRUG: Oral MRT-2359
DRUG: Oral MRT-2359
DRUG: Oral MRT-2359
DRUG: Oral MRT-2359
DRUG: Acalabrutinib
BIOLOGICAL: Obinutuzumab
DRUG: Venetoclax
RADIATION: Ultra Low Dose 4 Gy Radiation
DRUG: Acalabrutinib
BIOLOGICAL: CD19CAR-CD28-CD3zeta-EGFRt-expressing Tn/mem-enriched T-lymphocytes
DEVICE: Miltenyi CliniMACS Prodigy ® system
DRUG: SGN-35C
DRUG: Mogamulizumab-Kpkc
DEVICE: Phototherapy
BIOLOGICAL: OrcaGraft (Orca-Q)
DRUG: DOC Group B
DRUG: Pv-COMRAD 1 and 2 Group B
DRUG: Pv-R-CYM 1 and 2 Group B
DRUG: DOC Group C
DRUG: MAD CPR 1 and 2
DRUG: Pv-R CYVE 1 and 2
DRUG: Pv-R CYVE-MTX 1 and 2
DRUG: MAD CP
DRUG: Pv-Cytarabine/etoposide
DRUG: AD CP
DRUG: Bv-AVD-R 1 and 2: COHORT IIa
DRUG: Bv-NVD-R, Cycle 1-2
DRUG: Bv-NVD-R, Cycle 1-4 SER
DRUG: Bv-AVD-R
DRUG: Bv-NVD-R, Cycle 1-4 RER
DRUG: Bv-NAVD-R, Cycle 1-2
RADIATION: Involved Site Radiation Therapy
PROCEDURE: Biospecimen Collection
BIOLOGICAL: Bleomycin Sulfate
DRUG: Brentuximab Vedotin
PROCEDURE: Computed Tomography
DRUG: Cyclophosphamide
DRUG: Dacarbazine
DRUG: Doxorubicin Hydrochloride
DRUG: Etoposide
DRUG: Etoposide Phosphate
OTHER: Fludeoxyglucose F-18
RADIATION: Involved-site Radiation Therapy
PROCEDURE: Magnetic Resonance Imaging
BIOLOGICAL: Nivolumab
PROCEDURE: Positron Emission Tomography
DRUG: Prednisolone
DRUG: Prednisone
DRUG: Procarbazine Hydrochloride
OTHER: Questionnaire Administration
DRUG: Vinblastine Sulfate
DRUG: Vincristine Sulfate
DRUG: Epcoritamab
PROCEDURE: Bone Marrow Aspiration and Biopsy
PROCEDURE: Computed Tomography
PROCEDURE: Echocardiography
DRUG: Lenalidomide
PROCEDURE: Lumbar Puncture
PROCEDURE: Magnetic Resonance Imaging
DRUG: Methotrexate
BIOLOGICAL: Nivolumab
PROCEDURE: Positron Emission Tomography
BIOLOGICAL: Rituximab
PROCEDURE: Ultrasound Imaging
BIOLOGICAL: Rituximab
DRUG: Zanubrutinib
DRUG: Relatlimab
DRUG: Nivolumab
DRUG: BAFF CAR-T
DRUG: Low Dose Radiation Therapy
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Computed Tomography
BIOLOGICAL: Tafasitamab
DRUG: Zanubrutinib
DRUG: SGN-35T
DRUG: Venetoclax
DRUG: Obinutuzumab
DRUG: Rituximab
BIOLOGICAL: CTX131
DRUG: bendamustine
DRUG: Etoposide
DRUG: Doxorubicin
DRUG: Bleomycin
DRUG: Vincristine
DRUG: Vinblastine
DRUG: Prednisone
DRUG: Filgrastim
DRUG: Brentuximab Vedotin
DRUG: Cyclophosphamide
DRUG: DTIC
OTHER: Quality of Life Measurements
RADIATION: Radiotherapy
BIOLOGICAL: autologous hematopoietic stem cells added to planned CAR T
DEVICE: Alpha Beta T cell depletion
DRUG: Azacitidine
DRUG: Venetoclax
BIOLOGICAL: Nivolumab
DRUG: Pirtobrutinib
DRUG: Brexucabtagene Autoleucel
BIOLOGICAL: CD19-CAR(Mem) T-cells
DRUG: Cyclophosphamide
DRUG: Fludarabine
DRUG: Mesna
DEVICE: CliniMACS
PROCEDURE: Leukapheresis
BIOLOGICAL: CD4CAR
DRUG: Magnesium Chloride-based Lotion
OTHER: Quality-of-Life Assessment
BEHAVIORAL: Special Diet Therapy
PROCEDURE: Allogeneic Hematopoietic Stem Cell Transplantation
BIOLOGICAL: Basiliximab
DRUG: Fludarabine Phosphate
DRUG: Indium In 111-DOTA-Basiliximab
DRUG: Melphalan
BIOLOGICAL: Palifermin
RADIATION: Total Lymphoid Irradiation
RADIATION: Total Marrow Irradiation
BIOLOGICAL: Yttrium Y 90 Basiliximab
BIOLOGICAL: favezelimab/pembrolizumab
DRUG: bendamustine
DRUG: gemcitabine
DRUG: LP-118
OTHER: Pharmacokinetics
OTHER: Pharmacokinetics
DRUG: Prednisone
DRUG: Prednisolone
DRUG: Methylprednisolone
BIOLOGICAL: Rituximab
DRUG: Polatuzumab Vedotin
DRUG: Cyclophosphamide
DRUG: Doxorubicin Hydrochloride
BIOLOGICAL: Chimeric Antigen Receptor T-Cell Therapy
DRUG: Cyclophosphamide
DRUG: Fludarabine Phosphate
OTHER: Laboratory Biomarker Analysis
OTHER: Questionnaire Administration
DRUG: Cyclophosphamide
DRUG: Doxorubicin
DRUG: Vincristine
DRUG: Prednisone
DRUG: Etoposide
DRUG: Duvelisib
DRUG: Oral azacitidine
RADIATION: Adaptive Bridging Radiation Therapy (ABRT)
BIOLOGICAL: Blinatumomab
DRUG: Cytarabine
DRUG: Methotrexate
DRUG: Ponatinib
BIOLOGICAL: BI-1206
BIOLOGICAL: Pembrolizumab
BIOLOGICAL: Blinatumomab
BIOLOGICAL: Inotuzumab Ozogamicin
DRUG: Cyclophosphamide
DRUG: Doxorubicin Hydrochloride
DRUG: Prednisone
BIOLOGICAL: Rituximab
DRUG: Vincristine Sulfate
DRUG: Zanubrutinib
DRUG: Acalabrutinib
DRUG: Venetoclax
DRUG: Obinutuzumab
DRUG: Bortezomib
DRUG: Clofarabine
DRUG: Cyclophosphamide
DRUG: Dexamethasone
DRUG: Etoposide
BIOLOGICAL: Ofatumumab
BIOLOGICAL: Pegfilgrastim
BIOLOGICAL: Rituximab
DRUG: Vincristine Sulfate Liposome
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Computed Tomography
DRUG: Cyclophosphamide
DRUG: Fludarabine
PROCEDURE: Leukapheresis
BIOLOGICAL: Lisocabtagene Maraleucel
PROCEDURE: Lymph Node Biopsy
PROCEDURE: Positron Emission Tomography
DRUG: Zanubrutinib
DRUG: Pirtobrutinib
DRUG: Venetoclax
DRUG: Pemetrexed
DRUG: Zanubrutinib
PROCEDURE: Autologous Stem Cell Transplant (ASCT)
RADIATION: Whole Brain Radiation Therapy (WBRT)
BIOLOGICAL: BAFFR-CAR T cells
BIOLOGICAL: ATLCAR.CD30 T cells
DRUG: Bendamustine
DRUG: Fludarabine
DRUG: Cyclophosphamide
DRUG: Obinutuzumab
DRUG: Glofitamab
OTHER: Ossium HPC Marrow, Bone Marrow Transplant
OTHER: Pre-transplant conditioning - Myeloablative (MAC)
OTHER: Pre-transplant conditioning - Reduced Intensity (RIC)
OTHER: Post-transplant treatment
DRUG: PAXALISIB
RADIATION: Total-Body Irradiation
DRUG: Thiotepa
DRUG: Fludarabine
DRUG: Tacrolimus
BIOLOGICAL: Allogeneic CD34+-enriched and CD45RA-depleted PBSCs
DRUG: Methotrexate
DRUG: Cyclophosphamide
BIOLOGICAL: Peripheral Blood Stem Cell
DRUG: Cyclosporine
DRUG: Sirolimus
DRUG: Busulfan
PROCEDURE: Bone Marrow Aspiration and Biopsy
PROCEDURE: Echocardiography
PROCEDURE: Multigated Acquisition Scan
PROCEDURE: Biospecimen Collection
DRUG: Axicabtagene Ciloleucel
BIOLOGICAL: Loncastuximab Tesirine
DRUG: Glofitamab
DRUG: Obinutuzumab
DRUG: Tocilizumab
DRUG: DPX-Survivac
DRUG: Pembrolizumab
DRUG: CPA
BIOLOGICAL: PIT565
DRUG: Acalabrutinib
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspiration
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Computed Tomography
PROCEDURE: Echocardiography
BIOLOGICAL: Obinutuzumab
OTHER: Questionnaire Administration
BIOLOGICAL: Tafasitamab
DRUG: 131-I Apamistamab
BIOLOGICAL: CAR T-cell
DRUG: BGB-16673
PROCEDURE: Allogeneic Bone Marrow Transplantation
DRUG: Bendamustine
BIOLOGICAL: Filgrastim-sndz
DRUG: Fludarabine
BIOLOGICAL: Inotuzumab Ozogamicin
DRUG: Melphalan
PROCEDURE: Peripheral Blood Stem Cell Transplantation
BIOLOGICAL: Rituximab
DRUG: Tacrolimus
DRUG: IMT-009
COMBINATION_PRODUCT: Fruquintinib
DRUG: ABL001
DRUG: Dasatinib
DRUG: Prednisone
DRUG: Blinatumomab
PROCEDURE: AutoSCT OR CAR T-cell Therapy
DRUG: GDP
DRUG: Epcoritamab
DRUG: EAGD T-cell infusion (Phase I)
DRUG: EAGD T-cell infusion (Expansion)
DRUG: mosunetuzumab
DRUG: glofitamab
DRUG: obinutuzumab
DRUG: Venetoclax
DRUG: Lenalidomide
BIOLOGICAL: Rituximab
BIOLOGICAL: Rituximab and Hyaluronidase Human
DRUG: Acalabrutinib
BIOLOGICAL: Rituximab
DRUG: ATL-RIC
DRUG: mRIC
PROCEDURE: allo HCT
DRUG: RIC
DRUG: GVHD prophylaxis
DRUG: IOC
DRUG: AKR1C3-activated Prodrug OBI-3424
DRUG: Docirbrutinib
DRUG: STP938
DRUG: Fludarabine
DRUG: Cyclophosphamide
DRUG: JCAR017
DRUG: Fludarabine
DRUG: Cyclophosphamide
DRUG: CD70-CAR T cell infusion (Autologous)
DRUG: Mesna
DRUG: Cyclophosphamide
DRUG: Doxorubicin
DRUG: Etoposide
BIOLOGICAL: Loncastuximab Tesirine
DRUG: Prednisone
BIOLOGICAL: Rituximab
DRUG: Vincristine
DRUG: Zanubrutinib
BIOLOGICAL: Rituximab
OTHER: Patient Observation
PROCEDURE: Bone Marrow Biopsy
OTHER: Fludeoxyglucose F-18
PROCEDURE: Positron Emission Tomography
PROCEDURE: Computed Tomography
PROCEDURE: Magnetic Resonance Imaging
PROCEDURE: Esophagogastroduodenoscopy
PROCEDURE: Colonoscopy
PROCEDURE: Biospecimen Collection
OTHER: Questionnaire Administration
DRUG: Ritlecitinib
DRUG: Mosunetuzumab
DRUG: Tazemetostat Pill
DRUG: Nanatinostat in combination with valganciclovir
RADIATION: Bridging radiation therapy
BIOLOGICAL: Liso-cel
RADIATION: Post-infusion radiation
DRUG: IMPT-314
DRUG: Epcoritamab
DRUG: Rituximab
DRUG: Lenalidomide
DRUG: Oxaliplatin
DRUG: Gemcitabine
DRUG: L-Bcl-2 antisense oligonucleotide
BIOLOGICAL: BAFFR-CAR T cells
GENETIC: CB-010
DRUG: Cyclophosphamide
DRUG: Fludarabine
BIOLOGICAL: huCART19-IL18
PROCEDURE: Biopsy
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Computed Tomography
PROCEDURE: Positron Emission Tomography
BIOLOGICAL: Recombinant Vesicular Stomatitis Virus-expressing Human Interferon Beta and Sodium-Iodide Symporter
PROCEDURE: Single Photon Emission Computed Tomography
BIOLOGICAL: Cemiplimab
BIOLOGICAL: Ipilimumab
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspiration
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Computed Tomography
DRUG: Cyclophosphamide
DRUG: Doxorubicin Hydrochloride
PROCEDURE: Echocardiography
DRUG: Etoposide Phosphate
BIOLOGICAL: Filgrastim
PROCEDURE: Lumbar Puncture
BIOLOGICAL: Nivolumab
BIOLOGICAL: Pegfilgrastim
PROCEDURE: Positron Emission Tomography
DRUG: Prednisolone
DRUG: Prednisone
RADIATION: Radiation Therapy
BIOLOGICAL: Rituximab
BIOLOGICAL: Rituximab and Hyaluronidase Human
DRUG: Vincristine Sulfate
DRUG: NX-5948
DRUG: Venetoclax
DRUG: Obinutuzumab
DRUG: Acalabrutinib
DRUG: PRO1160
BIOLOGICAL: tabelecleucel
DRUG: CAR.k.28
DRUG: Fludarabine
DRUG: Cyclophosphamide
DRUG: Bendamustine
DRUG: Glofitamab
DRUG: Polatuzumab
DRUG: Rituximab
DRUG: Doxorubicin Hydrochloride
DRUG: Cyclophosphamide
DRUG: Prednisone
DRUG: Soquelitinib
DRUG: Belinostat
DRUG: Pralatrexate
DRUG: Hyper CVAD Protocol (Standard of Care Multi-Agent Chemotherapy)
DRUG: Calaspargase Pegol
DRUG: Rituximab
DRUG: BMF-219
DRUG: CC-220
DRUG: Rituximab
DRUG: Cyclophosphamide
DRUG: Doxorubicin
DRUG: Vincristine
DRUG: Prednisone
DRUG: CC-99282
DRUG: Polatuzumab vedotin
DRUG: Rituximab
DRUG: UVADEX® (methoxsalen) Sterile Solution in conjunction with the THERAKOS® CELLEX Photopheresis
DEVICE: THERAKOS® CELLEX photopheresis system
DRUG: Palbociclib
DRUG: Sunitinib
DRUG: Temsirolimus
DRUG: Trastuzumab and Pertuzumab
DRUG: Vemurafenib and Cobimetinib
DRUG: Regorafenib
DRUG: Olaparib
DRUG: Pembrolizumab
DRUG: Nivolumab and Ipilimumab
DRUG: Abemaciclib
DRUG: Talazoparib
DRUG: Atezolizumab and PHESGO
DRUG: Atezolizumab and Talazoparib
DRUG: Entrectinib
DRUG: Larotrectinib
DRUG: Tucatinib plus Trastuzumab Subcutaneous (SC)
DRUG: Futibatinib
DRUG: BMS-986458
DRUG: Rituximab
BIOLOGICAL: Anti-CD19-CAR CMV-specific T-lymphocytes
PROCEDURE: Autologous Hematopoietic Stem Cell Transplantation
BIOLOGICAL: Multi-peptide CMV-Modified Vaccinia Ankara Vaccine
PROCEDURE: Myeloablative Conditioning
DRUG: maplirpacept (PF-07901801)
DRUG: Glofitamab
DRUG: Obinutuzumab
BIOLOGICAL: JNJ-90014496
BIOLOGICAL: Blinatumomab
DRUG: Cyclophosphamide
DRUG: Cytarabine
DRUG: Dexamethasone
BIOLOGICAL: Inotuzumab Ozogamicin
OTHER: Laboratory Biomarker Analysis
DRUG: Mercaptopurine
DRUG: Methotrexate
DRUG: Prednisone
BIOLOGICAL: Rituximab
DRUG: Vincristine
DRUG: Acalabrutinib
DRUG: Isavuconazole
DRUG: CD38-SADA:177Lu-DOTA Complex
DRUG: PRT2527
DRUG: Zanubrutinib
DRUG: Venetoclax
DRUG: DR-01
DRUG: Venetoclax
DRUG: Zanubrutinib
BIOLOGICAL: CD30.CAR-EBVST cells
DRUG: Epcoritamab
DRUG: Odronextamab
DRUG: Lenalidomide
DRUG: Rituximab
DRUG: Cyclophosphamide
DRUG: Doxorubicin Hydrochloride
DRUG: Etoposide
BIOLOGICAL: Filgrastim
DRUG: Ibrutinib
OTHER: Laboratory Biomarker Analysis
BIOLOGICAL: Pegfilgrastim
OTHER: Pharmacological Study
DRUG: Prednisone
BIOLOGICAL: Rituximab
DRUG: Vincristine Sulfate
DRUG: CD19 Directed CAR T Cell
DRUG: Mosunetuzumab
DRUG: DHAX
DRUG: ICE
PROCEDURE: Biopsy
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspiration
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Computed Tomography
DRUG: Lenalidomide
PROCEDURE: Lumbar Puncture
PROCEDURE: Magnetic Resonance Imaging
PROCEDURE: Positron Emission Tomography
BIOLOGICAL: Tafasitamab
DRUG: Venetoclax
BIOLOGICAL: TmCD19-IL18
DRUG: Venetoclax
DRUG: Standard Chemotherapy
DRUG: Loncastuximab Tesirine
DRUG: Polatuzumab Vedotin
DRUG: Glofitamab
DRUG: Mosunetuzumab
DRUG: Obinutuzumab
DRUG: ABBV-101
DRUG: Bexarotene
RADIATION: Total Skin Electron Beam (TSEB)
DRUG: Siltuximab
DRUG: Akt/ERK Inhibitor ONC201
DRUG: Pirtobrutinib
DRUG: Venetoclax
DRUG: Brentuximab vedotin
DRUG: Doxorubicin Hydrochloride
DRUG: Pembrolizumab
DRUG: Dacarbazine
BIOLOGICAL: Rapcabtagene autoleucel single agent
DRUG: Ibrutinib
DEVICE: Magnetic-Activated Cell Sorter (CliniMACS, Miltenyi)
BIOLOGICAL: GEN3017
DRUG: brentuximab vedotin
DRUG: brentuximab vedotin
DRUG: brentuximab vedotin
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Computed Tomography
DRUG: Cyclophosphamide
DRUG: Doxorubicin Hydrochloride
DRUG: Etoposide
DRUG: Lenalidomide
PROCEDURE: Positron Emission Tomography
DRUG: Prednisone
DRUG: Vincristine Sulfate
DRUG: Palbociclib
DRUG: Dexamethasone
DRUG: Bortezomib
DRUG: Doxorubicin
DRUG: Cyclophosphamide
DRUG: Vincristine
DRUG: Dexamethasone
BIOLOGICAL: Inotuzumab Ozogamicin
DRUG: Methotrexate
DRUG: Cytarabine
DRUG: Methylprednisolone
BIOLOGICAL: Rituximab
DRUG: Prednisone
DRUG: Mercaptopurine
DRUG: Doxorubicin
DRUG: AZD3470
DRUG: Epcoritamab
DRUG: Prednisone
DRUG: Rituximab
DRUG: Lenalidomide
DRUG: Doxorubicin
DRUG: Vincristine
DRUG: Cyclophosphamide
DRUG: Obinutuzumab
DRUG: Bendamustine
DRUG: CD19CAR-CD3Zeta-4-1BB-Expressing Autologous T-Lymphocyte Cells
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspirate
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Echocardiography
DRUG: FACT Complex-targeting Curaxin CBL0137
DRUG: Golcadomide
DRUG: Placebo
DRUG: Rituximab
DRUG: Cyclophosphamide
DRUG: Doxorubicin
DRUG: Vincristine
DRUG: Prednisone
DRUG: Methotrexate
DRUG: Rituximab
DRUG: leucovorin
DRUG: Glucarpidase
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
DRUG: Lenalidomide
BIOLOGICAL: Mosunetuzumab
DRUG: Polatuzumab Vedotin
PROCEDURE: Positron Emission Tomography
BIOLOGICAL: Chimeric Antigen Receptor T-Cell Therapy
DRUG: Cyclophosphamide
DRUG: Fludarabine Phosphate
BIOLOGICAL: Tocilizumab
DRUG: CD22CART infusion
DRUG: Tisagenlecleucel
DRUG: etoposide
DRUG: cyclophosphamide
RADIATION: total marrow irradiation
PROCEDURE: allogeneic hematopoietic stem cell transplantation
PROCEDURE: allogeneic bone marrow transplantation
DRUG: Tulmimetostat
DRUG: SYNCAR-001
DRUG: STK-009
DRUG: Cyclophosphamide
DRUG: Fludarabine
DRUG: Acalabrutinib
DRUG: Bortezomib
DRUG: Cyclophosphamide
DRUG: Cytarabine
DRUG: Doxorubicin Hydrochloride
DRUG: Prednisone
BIOLOGICAL: Rituximab
BIOLOGICAL: Rituximab and Hyaluronidase Human
PROCEDURE: Allogeneic Hematopoietic Stem Cell Transplantation
PROCEDURE: Biospecimen Collection
DRUG: Granulocyte Colony-Stimulating Factor
DRUG: Hematopoietic Cell Transplantation Conditioning Regimen
BIOLOGICAL: Multi-peptide CMV-Modified Vaccinia Ankara Vaccine
PROCEDURE: Pheresis
DRUG: Placebo Administration
DRUG: Stem Cell Mobilization Therapy
DRUG: cemiplimab
DRUG: odronextamab
DRUG: Inotuzumab Ozogamicin
PROCEDURE: Aspiration
PROCEDURE: Biospecimen Collection
PROCEDURE: Catheterization
BIOLOGICAL: CD19CAR-CD28-CD3zeta-EGFRt-expressing Tcm-enriched T-lymphocytes
PROCEDURE: Computed Tomography
DRUG: Cyclophosphamide
DRUG: Fludarabine
PROCEDURE: Leukapheresis
PROCEDURE: Lumbar Puncture
PROCEDURE: Magnetic Resonance Imaging
PROCEDURE: Positron Emission Tomography
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
DRUG: Duvelisib
BIOLOGICAL: Nivolumab
PROCEDURE: Positron Emission Tomography
PROCEDURE: Punch Biopsy
DRUG: Bleximenib
DRUG: Belantamab Mafodotin
RADIATION: Comprehensive Ablative Bridging Irradiation (CABI)
BIOLOGICAL: Chimeric Antigen Receptor T-Cell Therapy
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
PROCEDURE: Magnetic Resonance Imaging
BIOLOGICAL: Mosunetuzumab
DRUG: Polatuzumab Vedotin
PROCEDURE: Positron Emission Tomography
OTHER: Questionnaire Administration
OTHER: Laboratory Biomarker Analysis
DRUG: Venetoclax
DRUG: Vincristine Liposomal
DRUG: DZ-002
DRUG: BMF-500
DRUG: Rituximab Prednisone
DRUG: Cyclophosphamide
DRUG: Doxorubicin
DRUG: Vincristine
DRUG: Prednisone
DRUG: 1A46 Injection
DRUG: Senza5 CART5
DRUG: 9-ING-41
DRUG: Irinotecan
DRUG: Temozolomide
DRUG: Cyclophosphamide
DRUG: Topotecan
DRUG: ONM-501
DRUG: Cemiplimab
DRUG: Blinatumomab
DRUG: Inotuzumab Ozogamicin
DRUG: Hyper-CVAD
DRUG: Mini-hyper-CVD
BIOLOGICAL: P-CD19CD20-ALLO1
DRUG: Rimiducid
DRUG: Pembrolizumab
DRUG: Glofitamab
DRUG: Polatuzumab vedotin
DRUG: Rituximab
DRUG: Cyclophosphamide
DRUG: Doxorubicin
DRUG: Prednisone
DRUG: SLS009
DRUG: venetoclax
DRUG: azacitidine
DRUG: SC262
DRUG: Autologous Anti-CD19 CAR-expressing T Lymphocytes
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspiration and Biopsy
DRUG: Cyclophosphamide
DRUG: Fludarabine
PROCEDURE: Leukapheresis
OTHER: Questionnaire Administration
DRUG: Ibrutinib
BIOLOGICAL: Obinutuzumab
DRUG: Venetoclax
DRUG: Vactosertib
DRUG: Fludarabine Phosphate
DRUG: Cyclophosphamide
DRUG: IL-2
DRUG: Natural Killer Cells
DRUG: Ascentage Pharma HQP1351 bioavailable inhibitor
DRUG: Blinatumomab
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspiration
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Computed Tomography
DRUG: Pirtobrutinib
DRUG: Venetoclax
DRUG: Selinexor (combination therapy)
DRUG: Selinexor (combination therapy)
DRUG: Selinexor (combination therapy)
DRUG: Placebo matching for Selinexor (combination therapy)
DRUG: Rituximab (combination therapy)
DRUG: Rituximab (combination therapy)
DRUG: Gemcitabine (combination therapy)
DRUG: Dexamethasone (combination therapy)
DRUG: Cisplatin (combination therapy)
DRUG: Selinexor (continuous therapy)
DRUG: Placebo matching for Selinexor (continuous therapy)
PROCEDURE: Biopsy
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
BIOLOGICAL: Epcoritamab
PROCEDURE: Magnetic Resonance Imaging
OTHER: Patient Observation
PROCEDURE: Positron Emission Tomography
DRUG: Pembrolizumab
DRUG: Lymphodepletion Chemotherapy
DRUG: Chimeric Antigen Receptor (CAR) Therapy Infusion
PROCEDURE: Leukapheresis
DRUG: N803
BIOLOGICAL: CD19t-haNK suspension
DRUG: Cyclophosphamide
DRUG: Fludarabine
DRUG: Rituximab
PROCEDURE: Biospecimen Collection
BIOLOGICAL: Blinatumomab
PROCEDURE: Bone Marrow Aspiration and Biopsy
DRUG: Cyclophosphamide
DRUG: Cytarabine
DRUG: Dasatinib
DRUG: Dexamethasone
DRUG: Doxorubicin Hydrochloride
PROCEDURE: Echocardiography
PROCEDURE: Electrocardiography
PROCEDURE: Lumbar Puncture
DRUG: Mesna
DRUG: Methotrexate
PROCEDURE: Multigated Acquisition Scan
DRUG: Ponatinib Hydrochloride
DRUG: Prednisone
DRUG: Vincristine Sulfate
DRUG: JNJ-80948543
DRUG: Fludarabine
DRUG: Cytoxan
RADIATION: Total Body Irradiation
PROCEDURE: Allogeneic Blood or Marrow Transplant
PROCEDURE: Peripheral Blood Stem Cell Transplant
DRUG: Mycophenolate Mofetil
DRUG: Sirolimus
DRUG: Tacrolimus
DRUG: Duvelisib
DRUG: Odronextamab
DRUG: Rituximab
DRUG: Cyclophosphamide
DRUG: Doxorubicin
DRUG: Vincristine
DRUG: Prednisone/Prednisolone
DRUG: Mosunetuzumab
DRUG: Polatuzumab
BIOLOGICAL: CAR-T Cell Therapy
DRUG: NVL-655
DRUG: SIM1811-03
DRUG: Etoposide
DRUG: Doxorubicin
DRUG: Cyclophosphamide
DRUG: Rituximab
DRUG: Vincristine
DRUG: Prednisone
DRUG: Loncastuximab Tesirine 0.075 mg/kg by IV
DRUG: Loncastuximab tesirine 0.12 mg/kg by IV
DRUG: Loncastuximab tesirine 0.15 mg/kg by IV
DRUG: ATG-101
BIOLOGICAL: SynKIR-310
BIOLOGICAL: HSCT with TBI Regimen
BIOLOGICAL: HSCT with Non-TBI Regimen
DRUG: NX-1607
DRUG: Paclitaxel
BIOLOGICAL: 8/12-Day Production of Car-T Cells
BIOLOGICAL: 8/12-Day Production of Cryopreserved Car-T Cells
BIOLOGICAL: 12-Day Production of Car-T Cells
PROCEDURE: Biopsy
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Computed Tomography
DRUG: Cyclophosphamide
PROCEDURE: Positron Emission Tomography
BIOLOGICAL: Recombinant Vesicular Stomatitis Virus-expressing Human Interferon Beta and Sodium-Iodide Symporter
PROCEDURE: Single Photon Emission Computed Tomography
BIOLOGICAL: Cemiplimab
DRUG: Ibrutinib
DRUG: Venetoclax
DRUG: Epcoritamab
DRUG: Rituximab
DRUG: Lenalidomide
DRUG: Venetoclax
DRUG: Tazemetostat
DRUG: alpha beta depletion
DRUG: Epcoritamab
DRUG: Lenalidomide
DRUG: Ibrutinib
DRUG: Rituximab
DRUG: Cyclophosphamide
DRUG: Doxorubicin Hydrochloride [HCl]
DRUG: Prednisone
DRUG: Polatuzumab Vedotin
DRUG: Venetoclax
DRUG: CC-99282
DRUG: Pirtobrutinib
DRUG: ATRA
DRUG: Pembrolizumab
DRUG: Tazemetostat
DRUG: Polatuzumab vedotin
DRUG: Rituximab
DRUG: CHP
DRUG: Polatuzumab vedotin (PV)
DRUG: Rituximab
DRUG: Hyaluronidase
DRUG: Gemcitabine
DRUG: Cisplatin
DRUG: Dexamethasone
DRUG: GCSF
DRUG: Ibrutinib
DRUG: HD- Methotrexate (MTX)
DRUG: Rituximab + HD- Methotrexate (MTX)
DRUG: procarbazine
DRUG: Darzalex Faspro (Daratumumab and hyaluronidase-fihj)
DEVICE: JH-DSA Semi-Quant Screen and Response Score
BIOLOGICAL: Anti-CD19 CAR-T cells
DRUG: Obinutuzumab
DRUG: Liposomal ARA-C
DRUG: Ifosfamide
DRUG: Carboplatin
DRUG: Etoposide
BIOLOGICAL: ATLCAR.CD30.CCR4 cells
BIOLOGICAL: ALTCAR.CD30 cells
DRUG: Bendamustine
DRUG: Fludarabine
DRUG: Brentuximab vedotin
DRUG: Doxorubicin
DRUG: Vinblastine
DRUG: Dacarbazine
DRUG: Pembrolizumab
DRUG: Gemcitabine
DRUG: Vinorelbine
DIAGNOSTIC_TEST: FDG-PET/CT scan
DRUG: Ibrutinib
BIOLOGICAL: Obinutuzumab
OTHER: Laboratory Biomarker Analysis
DRUG: Isavuconazole
DRUG: TEDDI
BIOLOGICAL: Rituximab
DRUG: Cytarabine
DRUG: TEDD
DRUG: Ibrutinib (Arms 2, 3 and 4)
DRUG: Methotrexate
DRUG: Ibrutinib (Arm 1 - Closed with Amendment G)
DRUG: Ibrutinib (Arm 4)
DRUG: Cyclophosphamide
DRUG: Cytarabine
DRUG: Dexamethasone
DRUG: Doxorubicin Hydrochloride
DRUG: Mercaptopurine
DRUG: Methotrexate
DRUG: Nelarabine
DRUG: Pegaspargase
DRUG: Prednisone
DRUG: Venetoclax
DRUG: Vincristine Sulfate
DRUG: Zanubrutinib
DRUG: Rituximab
DRUG: Lenalidomide
DRUG: Obinutuzumab
DRUG: Fludarabine Phosphate
DRUG: Melphalan
RADIATION: Intensity-Modulated Radiation Therapy
RADIATION: Total Marrow Irradiation
PROCEDURE: Allogeneic Hematopoietic Stem Cell Transplantation
PROCEDURE: Peripheral Blood Stem Cell Transplantation
PROCEDURE: Allogeneic Bone Marrow Transplantation
DRUG: Tacrolimus
DRUG: Mycophenolate Mofetil
OTHER: Laboratory Biomarker Analysis
DRUG: Pirtobrutinib
DRUG: Obinutuzumab
BIOLOGICAL: bbT369
DRUG: Fludarabine
DRUG: Cyclophosphamide
BIOLOGICAL: anti-CD19 CAR-T cells
GENETIC: cemacabtagene ansegedleucel
BIOLOGICAL: ALLO-647
DRUG: Fludarabine
DRUG: Cyclophosphamide
DEVICE: Foresight CLARITY™ IUO MRD test, powered by PhasED-Seq™
BEHAVIORAL: Cognitive Behavioral Therapy for Insomnia
DRUG: Obinutuzumab
DRUG: ABBV-453
BIOLOGICAL: UCART20x22
BIOLOGICAL: CLLS52
DRUG: Fludarabine (Conditional therapy)
DRUG: Cyclophosphamide Monohydrate (Conditional therapy)
DRUG: firi-cel (Experimental drug)
DRUG: Acalabrutinib
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Computed Tomography
PROCEDURE: Echocardiography
BIOLOGICAL: Glofitamab
PROCEDURE: Multigated Acquisition Scan
BIOLOGICAL: Obinutuzumab
PROCEDURE: Positron Emission Tomography
BIOLOGICAL: Axicabtagene Ciloleucel
DRUG: Cyclophosphamide
DRUG: Fludarabine
DRUG: CPI-0209
DRUG: MGD024
RADIATION: Focal radiation therapy (RT)
DRUG: Belinostat Injection
DRUG: Pralatrexate Injection
DRUG: CHOP
DRUG: COP
DRUG: ATG-031
BIOLOGICAL: Dilanubicel
DRUG: Cyclophosphamide
DRUG: Fludarabine
DRUG: Thiotepa
RADIATION: Total-Body Irradiation
PROCEDURE: Umbilical Cord Blood Transplantation
OTHER: Laboratory Biomarker Analysis
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspirate
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Multigated Acquisition Scan
PROCEDURE: Electrocardiography
PROCEDURE: Computed Tomography
DRUG: Oral Azacitidine
GENETIC: Dose Escalation Phase:CD19.CAR/28 and CD19.CAR/28137 T cells
GENETIC: Expansion Phase: CD19.CAR/28 and CD19.CAR/28137 T cells
DRUG: Brentuximab Vedotin
PROCEDURE: Hematopoietic Cell Transplantation
BIOLOGICAL: Nivolumab
OTHER: Quality-of-Life Assessment
OTHER: Questionnaire Administration
DRUG: Allogeneic donor-derived T-cells transduced with bivalent lentiviral vector (CD19/CD22-BBz) chimeric antigen receptor (CAR)
DRUG: Treg CD34+HSPC (Orca-T)
DRUG: Ibrutinib
DRUG: Pembrolizumab
DRUG: Rituximab
BIOLOGICAL: Pembrolizumab Coformulated With Hyaluronidase
DRUG: Brentuximab vedotin
PROCEDURE: Biopsy
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspiration and Biopsy
PROCEDURE: Computed Tomography
DRUG: Cyclophosphamide
DRUG: Doxorubicin
PROCEDURE: Echocardiography
DRUG: Etoposide
PROCEDURE: Magnetic Resonance Imaging
BIOLOGICAL: Mosunetuzumab
PROCEDURE: Multigated Acquisition Scan
PROCEDURE: Positron Emission Tomography
DRUG: Prednisone
DRUG: Vincristine
DRUG: Odronextamab
DRUG: REGN5837
DRUG: Epcoritamab
DRUG: Cyclophosphamide
DRUG: Rituximab
DRUG: Vincristine
DRUG: Doxorubicin
DRUG: Prednisone
PROCEDURE: Biopsy
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspiration
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Computed Tomography
DRUG: Cyclophosphamide
PROCEDURE: Echocardiography
BIOLOGICAL: EGFRt/19-28z/IL-12 CAR T-lymphocytes
DRUG: Fludarabine Phosphate
PROCEDURE: Leukapheresis
PROCEDURE: Multigated Acquisition Scan
PROCEDURE: Positron Emission Tomography
RADIATION: Radiation - Dose Level 0
RADIATION: Radiation - Dose Level 1
RADIATION: Radiation - Dose Level 2
RADIATION: Radiation - Dose Level 3
RADIATION: Radiation - Dose Level 4
BIOLOGICAL: Kappa CD28 T cells
DRUG: Blinatumomab
Get the latest thought leadership on your T-Cell Prolymphocytic Leukemia delivered straight to your inbox
Subscribe to the weekly newsletter for news, stories, clinical trial updates, and helpful resources and events with cancer experts.